FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Lasmiditan Succinate Tablet
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Eli Lilly and Co. (New 11/03/2025)

Company Contact Information:
800-545-5979

Presentation	Posting Date	Related Information
Reyvow, Tablet, 50 mg (NDC 0002-4312-08)	11/03/2025	A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Reyvow, Tablet, 50 mg (NDC 0002-4312-61)	11/03/2025	A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Reyvow, Tablet, 50 mg (NDC 0002-4312-62)	11/03/2025	A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Reyvow, Tablet, 100 mg (NDC 0002-4491-08)	11/03/2025	A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Reyvow, Tablet, 100 mg (NDC 0002-4491-61)	11/03/2025	A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Reyvow, Tablet, 100 mg (NDC 0002-4491-62)	11/03/2025	A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.